Estefanía Prochetto

Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype

Estefanía Prochetto, Carolina Roldán, Iván Bontempi et al. · Oncotarget · 2017 · 33 citations · Full text

Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype

Ingrid M. Quintana, Martín Espariz, Silvina R. Villar et al. · Frontiers in Microbiology · 2018 · 27 citations · Full text

Trans-Sialidase Overcomes Many Antigens to be Used as a Vaccine Candidate Against <i>Trypanosoma Cruzi</i>

Iván Bontempi, Pedro Fleitas, Alexia Ayelén Poato et al. · Immunotherapy · 2017 · 25 citations · Full text

Recombinant <i>Mycobacterium bovis</i> BCG is a promising platform to develop vaccines against <i>Trypansoma cruzi</i> infection

Iván Bontempi, Karla Leal, Estefanía Prochetto et al. · Clinical & Experimental Immunology · 2020 · 20 citations · Full text

Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection

Estefanía Prochetto, Iván Bontempi, Luz Rodeles et al. · Acta Tropica · 2022 · 19 citations

Vaccination, African Trypanosomiasis, Parasitic Protozoa +5